The New Zealand Dollar gains 0.22% against the US Dollar amid steady PBoC rates but remains constrained by geopolitical risks. NZD/USD climbed 0.22% to 0.5850 on Wednesday, reflecting modest strength in the New Zealand Dollar. The pair’s upside was capped by persistent dem
TradingView data shows Bitfinex bitcoin margin longs rose to 80,636 BTC, the highest since December 2023, despite bitcoin falling for five straight trading days from May 15 to 19. Longs increased about 1.5% in recent days and roughly 10% year-to-date, while bitcoin is down
Sonoro Gold (SGO:CA) announced on Wednesday a non-brokered private placement offering consisting of 40M units at C$0.25 per unit, for gross proceeds of C$10M. Each unit will consist of one common share and one common share purchase warrant Each warrant will
Futures for the Dow Jones Industrial Average and other major stock indexes rose Wednesday, as Wall Street awaited the minutes from the Federal Reserve's latest policy meeting. Meanwhile, Nvidia (NVDA) was an early winner on the stock market today ahead of the company's hig
Nvidia’s quarterly revenue guidance of $78 billion reflects uncertainty in AI demand as industry shifts outpace earnings visibility. Nvidia has guided quarterly revenue to $78 billion, excluding China sales, with a 2% margin of error. The company’s market cap, currently at
Midstream energy partnerships and preferred stocks offer 7% yields, meeting retirement income targets the S&P 500 cannot match. A $475,000 portfolio targeting $33,600 in annual income requires a 7% yield, far above the S&P 500’s sub-2% average. Traditional index funds fall
American Resources Corp (NASDAQ:AREC) said on Wednesday it has completed a multi-year transformation away from metallurgical coal into a rare earth and critical mineral supply chain platform. As part of the restructuring, American Resources has separated its legacy coal op
Medicare expands coverage for Personalis' NeXT Personal minimal residual disease test, boosting potential U.S. market access. Personalis (PSNL) shares climbed approximately 5% in premarket trading after securing its fourth Medicare coverage decision for NeXT Personal, a mi
Uniqure NV targets UK regulatory approval for Huntington’s gene therapy AMT-130 in Q3 2026 after strong Phase 1/2 trial results. Uniqure NV (NASDAQ:QURE) shares have climbed 60% in the past month and over 100% year-to-date, driven by progress in its gene therapy pipeline.
Rabobank cites reduced Bank of England tightening expectations and UK political uncertainty as key drivers for pound weakness. The British pound faces downward pressure as markets scale back expectations for aggressive Bank of England rate hikes. Recent UK labor and inflat
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.